Lifen Yang

2.0k total citations
82 papers, 1.5k citations indexed

About

Lifen Yang is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Lifen Yang has authored 82 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Genetics and 16 papers in Oncology. Recurrent topics in Lifen Yang's work include Genetics and Neurodevelopmental Disorders (20 papers), Genomics and Rare Diseases (9 papers) and Epilepsy research and treatment (9 papers). Lifen Yang is often cited by papers focused on Genetics and Neurodevelopmental Disorders (20 papers), Genomics and Rare Diseases (9 papers) and Epilepsy research and treatment (9 papers). Lifen Yang collaborates with scholars based in China, United States and Japan. Lifen Yang's co-authors include Fei Yin, Jing Peng, Fang He, Xiaolu Deng, Jian Zhang, Nan Pang, Miriam Kessi, Chen Chen, Haiyan Ying and Zhenping Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Scientific Reports.

In The Last Decade

Lifen Yang

75 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lifen Yang China 22 553 315 269 200 196 82 1.5k
Ignazio S. Piras United States 22 720 1.3× 292 0.9× 238 0.9× 100 0.5× 129 0.7× 86 1.6k
Cristina Agliardi Italy 22 374 0.7× 191 0.6× 309 1.1× 95 0.5× 113 0.6× 63 1.3k
Ye Wu China 24 1.2k 2.2× 501 1.6× 183 0.7× 395 2.0× 262 1.3× 173 2.3k
Claus Jürgen Scholz Germany 27 844 1.5× 195 0.6× 244 0.9× 157 0.8× 125 0.6× 70 2.1k
Junli Zhao China 25 697 1.3× 192 0.6× 440 1.6× 136 0.7× 289 1.5× 76 1.8k
Katrin Hoffmann Germany 19 724 1.3× 327 1.0× 64 0.2× 219 1.1× 338 1.7× 31 1.7k
Fang He China 20 623 1.1× 410 1.3× 107 0.4× 231 1.2× 191 1.0× 59 1.3k
Mohammad A. Karim United States 20 868 1.6× 222 0.7× 350 1.3× 47 0.2× 384 2.0× 47 2.1k

Countries citing papers authored by Lifen Yang

Since Specialization
Citations

This map shows the geographic impact of Lifen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifen Yang more than expected).

Fields of papers citing papers by Lifen Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lifen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifen Yang. The network helps show where Lifen Yang may publish in the future.

Co-authorship network of co-authors of Lifen Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Lifen Yang. A scholar is included among the top collaborators of Lifen Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifen Yang. Lifen Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Xiaolu, J. Y. Zhao, Jian Li, et al.. (2025). A Case Series of Anti-Metabotropic Glutamate Receptor 2 Antibody-Related Diseases with Distinct Neurological Involvement. ImmunoTargets and Therapy. Volume 14. 465–474.
2.
Zhang, Ciliu, Zhong-Liang Zhang, Xiaole Wang, et al.. (2025). Gene therapy with covalently closed-end AAV vector for spinal muscular atrophy. Molecular Therapy. 33(10). 4848–4857.
3.
4.
Kessi, Miriam, Fang He, Ciliu Zhang, et al.. (2025). Anti-GAD65 Antibodies Related Refractory Epilepsy Successfully Treated with Tocilizumab: A Case Report and Systematic Literature Review. ImmunoTargets and Therapy. Volume 14. 491–500.
5.
Kessi, Miriam, et al.. (2024). Anti-GluK2 Encephalitis in an Asian Child: A Case Report and Literature Review. ImmunoTargets and Therapy. Volume 13. 805–811.
6.
Yang, Lifen, et al.. (2024). Application of Machine-learning based on Radiomics Features in DifferentialDiagnosis of Superficial Lymphadenopathy. Current Medical Imaging Formerly Current Medical Imaging Reviews. 20. e15734056272324–e15734056272324. 1 indexed citations
7.
Wang, Guoli, Miriam Kessi, Xi Huang, et al.. (2024). Treatment of juvenile myasthenia gravis with tacrolimus: A cohort study. European Journal of Neurology. 31(12). e16466–e16466.
8.
Pang, Nan, Kuokuo Li, Meilin Chen, et al.. (2023). Targeted sequencing identifies risk variants in 202 candidate genes for neurodevelopmental disorders. Gene. 897. 148071–148071. 1 indexed citations
9.
10.
Xiong, Juan, Baiyu Chen, Ciliu Zhang, et al.. (2021). Autism spectrum disorder and comorbid neurodevelopmental disorders (ASD-NDDs): Clinical and genetic profile of a pediatric cohort. Clinica Chimica Acta. 524. 179–186. 10 indexed citations
11.
Kessi, Miriam, Baiyu Chen, Jing Peng, et al.. (2020). Intellectual Disability and Potassium Channelopathies: A Systematic Review. Frontiers in Genetics. 11. 614–614. 34 indexed citations
12.
Chen, Baiyu, Miriam Kessi, Juan Xiong, et al.. (2020). The Recommendations for the Management of Chinese Children With Epilepsy During the COVID-19 Outbreak. Frontiers in Pediatrics. 8. 495–495. 4 indexed citations
13.
Yang, Lifen, et al.. (2019). Modulation of B cell activation threshold mediated by BCR/CD40 costimulation by targeting Cbl-b for ubiquitination. Biochemistry and Biophysics Reports. 18. 100641–100641. 5 indexed citations
14.
Guang, Shiqi, Nan Pang, Xiaolu Deng, et al.. (2018). Synaptopathology Involved in Autism Spectrum Disorder. Frontiers in Cellular Neuroscience. 12. 470–470. 197 indexed citations
15.
16.
Lonardi, Sara, Takayuki Yoshino, Radka Obermannová, et al.. (2016). Exposure-response (E-R) relationship of Ramucirumab (RAM) from a global, randomized, double-blind, Phase 3 study of patients (Pts) with advanced 2nd line colorectal cancer. Annals of Oncology. 27. iv40–iv40. 1 indexed citations
17.
Wang, Xiaole, Fang He, Fei Yin, et al.. (2016). The use of targeted genomic capture and massively parallel sequencing in diagnosis of Chinese Leukoencephalopathies. Scientific Reports. 6(1). 35936–35936. 10 indexed citations
18.
Qiao, Guilin, Lifen Yang, Zhenping Li, James W. Williams, & Jian Zhang. (2015). A77 1726, the active metabolite of leflunomide, attenuates lupus nephritis by promoting the development of regulatory T cells and inhibiting IL-17-producing double negative T cells. Clinical Immunology. 157(2). 166–174. 23 indexed citations
19.
Qiao, Guilin, Lifen Yang, Zhenping Li, et al.. (2012). Program death-1 regulates peripheral T cell tolerance via an anergy-independent mechanism. Clinical Immunology. 143(2). 128–133. 12 indexed citations
20.
He, Fang, et al.. (2012). PKC and RhoA signals cross-talk in Escherichia coli endotoxin induced alterations in brain endothelial permeability. Biochemical and Biophysical Research Communications. 425(2). 182–188. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ignazio S. Piras Breakdown of academic impact, for papers by Cristina Agliardi Breakdown of academic impact, for papers by Ye Wu Breakdown of academic impact, for papers by Claus Jürgen Scholz Breakdown of academic impact, for papers by Junli Zhao Breakdown of academic impact, for papers by Katrin Hoffmann Breakdown of academic impact, for papers by Fang He Breakdown of academic impact, for papers by Mohammad A. Karim
Rankless by CCL
2026